Squarepoint Ops LLC Century Therapeutics, Inc. Transaction History
Squarepoint Ops LLC
- $80.7 Billion
- Q1 2025
A detailed history of Squarepoint Ops LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 132,929 shares of IPSC stock, worth $77,098. This represents 0.0% of its overall portfolio holdings.
Number of Shares
132,929
Previous 164,871
19.37%
Holding current value
$77,098
Previous $166,000
62.05%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IPSC
# of Institutions
72Shares Held
27.4MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.14 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$1.86 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.68 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.45 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.38 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $34.2M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...